Literature DB >> 15153517

Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury.

Carmen Gómez-Guerrero1, Oscar López-Franco, Guillermo Sanjuán, Purificación Hernández-Vargas, Yusuke Suzuki, Guadalupe Ortiz-Muñoz, Julia Blanco, Jesús Egido.   

Abstract

Suppressors of cytokine signaling (SOCS) are cytokine-inducible proteins that modulate receptor signaling via tyrosine kinase pathways. We investigate the role of SOCS in renal disease, analyzing whether SOCS regulate IgG receptor (FcgammaR) signal pathways. In experimental models of immune complex (IC) glomerulonephritis, the renal expression of SOCS family genes, mainly SOCS-3, significantly increased, in parallel with proteinuria and renal lesions, and the proteins were localized in glomeruli and tubulointerstitium. Induction of nephritis in mice with a deficiency in the FcgammaR gamma-chain (gamma(-/-) mice) resulted in a decrease in the renal expression of SOCS-3 and SOCS-1. Moreover, blockade of FcgammaR by Fc fragment administration in rats with ongoing nephritis selectively inhibited SOCS-3 and SOCS-1, without affecting cytokine-inducible Src homology 2-containing protein and SOCS-2. In cultured human mesangial cells (MC) and monocytes, IC caused a rapid and transient induction of SOCS-3 expression. Similar kinetics was observed for SOCS-1, whereas SOCS-2 expression was very low. MC from gamma(-/-) mice failed to respond to IC activation, confirming the participation of FcgammaR. Interestingly, IC induced tyrosine phosphorylation of SOCS-3 and Tec tyrosine kinase, and both proteins coprecipitated in lysates from IC-stimulated MC, suggesting intracellular association. IC also activated STAT pathway in MC, which was suppressed by SOCS overexpression, mainly SOCS-3. In SOCS-3 knockdown studies, specific antisense oligonucleotides inhibited mesangial SOCS-3 expression, leading to an increase in the IC-induced STAT activation. Our results indicate that SOCS may play a regulatory role in FcgammaR signaling, and implicate SOCS as important modulators of cell activation during renal inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153517     DOI: 10.4049/jimmunol.172.11.6969

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

2.  Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Authors:  Jiping Zhao; Hao Yu; Yudong Liu; Sara A Gibson; Zhaoqi Yan; Xin Xu; Amit Gaggar; Pui-Kai Li; Chenglong Li; Shi Wei; Etty N Benveniste; Hongwei Qin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

3.  Suppressors of cytokine signaling abrogate diabetic nephropathy.

Authors:  Guadalupe Ortiz-Muñoz; Virginia Lopez-Parra; Oscar Lopez-Franco; Paula Fernandez-Vizarra; Beñat Mallavia; Claudio Flores; Ana Sanz; Julia Blanco; Sergio Mezzano; Alberto Ortiz; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

4.  Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.

Authors:  Chunguang Yan; Peter A Ward; Ximo Wang; Hongwei Gao
Journal:  FASEB J       Date:  2013-04-12       Impact factor: 5.191

5.  Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma.

Authors:  Anja Urbschat; Svenja Stumpf; Jörg Hänze; Patrick Paulus; Thorsten J Maier; Christine Weipert; Rainer Hofmann; Axel Hegele
Journal:  Tumour Biol       Date:  2016-01-22

Review 6.  Induction and termination of inflammatory signaling in group B streptococcal sepsis.

Authors:  Julia Wennekamp; Philipp Henneke
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

7.  Fcγ receptor deficiency attenuates diabetic nephropathy.

Authors:  Virginia Lopez-Parra; Beñat Mallavia; Oscar Lopez-Franco; Guadalupe Ortiz-Muñoz; Ainhoa Oguiza; Carlota Recio; Julia Blanco; Falk Nimmerjahn; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

8.  Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway.

Authors:  Wei-Na Duan; Zhong-Yuan Xia; Min Liu; Qian Sun; Shao-Qing Lei; Xiao-Jing Wu; Qing-Tao Meng; Yan Leng
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

9.  Activation of PI3K in response to high glucose leads to regulation of SOCS-3 and STAT1/3 signals and induction of glomerular mesangial extracellular matrix formation.

Authors:  Meei-Ling Sheu; Chin-Chang Shen; Jia-Rong Jheng; Chih-Kang Chiang
Journal:  Oncotarget       Date:  2017-03-07

10.  MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1.

Authors:  Rui Yao; Yu-Lan Ma; Wei Liang; Huan-Huan Li; Zhi-Jun Ma; Xian Yu; Yu-Hua Liao
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.